Literature DB >> 10926806

Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: a preliminary report.

J O Schorge1, K R Lee, E E Sheets.   

Abstract

OBJECTIVE: Microinvasive cervical adenocarcinoma has an excellent prognosis and emerging data support the hypothesis that it should be treated in the same way as its squamous counterpart. We report our preliminary experience prospectively treating stage IA(1) cervical adenocarcinoma by conization alone in women who strongly desired to preserve their fertility.
METHODS: Since May 1998, all patients with stage IA(1) cervical adenocarcinoma who expressed a strong desire to preserve fertility have been offered cold knife conization (CKC) and careful surveillance without hysterectomy. Women with lesions identifiable only microscopically, up to 3 mm invasive depth, up to 7 mm tumor width, and a conization specimen including the entire lesion with negative margins were eligible for conservative management. Postconization surveillance consisted of a Pap smear and endocervical curettage every 4 months. Medical records were reviewed for clinical data, follow-up, and disease status.
RESULTS: Five women ages 26-33 elected CKC and surveillance. Four were nulliparous and one primiparous. Four tumors were endocervical cell type; one was adenosquamous. Three were grade 1, one was grade 2, and one grade 3. None had lymph-vascular space invasion. None of the patients has developed recurrent disease after 6-20 months of follow-up.
CONCLUSIONS: Our preliminary data suggest that patients with FIGO stage IA(1) cervical adenocarcinoma who strongly desire to preserve their fertility may be treated by conization alone if they are fully informed of the unknown risks for disease recurrence and are carefully followed. A multicenter trial is the next logical step to test the efficacy of this approach. Copyright 2000 Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 10926806     DOI: 10.1006/gyno.2000.5857

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  Surveillance patterns of cervical cancer patients treated with conization alone.

Authors:  Silvana Pedra Nobre; Varvara Mazina; Alexia Iasonos; Qin C Zhou; Yukio Sonoda; Ginger Gardner; Kara Long-Roche; Mario M Leitao; Nadeem R Abu-Rustum; Jennifer J Mueller
Journal:  Int J Gynecol Cancer       Date:  2020-06-03       Impact factor: 3.437

2.  Preoperative pathologic findings associated with residual disease at radical hysterectomy in women with stage IA2 cervical cancer.

Authors:  Anuj Suri; Michael Frumovitz; Michael R Milam; Ricardo dos Reis; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2008-10-25       Impact factor: 5.482

Review 3.  Adenocarcinoma of the cervix.

Authors:  John O Schorge; Lynne M Knowles; Jayanthi S Lea
Journal:  Curr Treat Options Oncol       Date:  2004-04

4.  Tumor volume and lymphovascular space invasion as a prognostic factor in early invasive adenocarcinoma of the cervix.

Authors:  Isao Murakami; Takuma Fujii; Kaori Kameyama; Takashi Iwata; Miyuki Saito; Kaneyuki Kubushiro; Daisuke Aoki
Journal:  J Gynecol Oncol       Date:  2012-07-02       Impact factor: 4.401

5.  Conservative Treatment of Stage IA1 Adenocarcinoma of the Uterine Cervix during Pregnancy: Case Report and Review of the Literature.

Authors:  Francesco Sopracordevole; Diego Rossi; Jacopo Di Giuseppe; Marta Angelini; Pierino Boschian-Bailo; Monica Buttignol; Andrea Ciavattini
Journal:  Case Rep Obstet Gynecol       Date:  2014-03-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.